KWF
Validation of Biomarkers
Pre-proposal deadline: 20 October 2026 at 12:00 noon. Full proposal deadline: 23 February 2027 at 12:00 noon.
Last verified:
Details
| Funder | KWF |
| Budget | €0.8M–€2M |
| Deadline | 20 October 2026 |
| Duration | 2-5 years |
| Consortium | Required — minimum 4 participating parties (may include private partners) |
| Application | 2-stage: pre-proposal (opens 25 Aug 2026, closes 20 Oct 2026) → full proposal (opens 15 Dec 2026, closes 23 Feb 2027), followed by interviews in May 2027 |
| TRL | 5-6 |
| Frequency | Annual |
| Eligible countries | NL |
Eligibility & scope
Clinical validation of known oncology biomarkers (TRL5/6) for use in daily clinical practice. Requires multidisciplinary consortium of ≥4 parties including biostatistician and HTA expert; patient involvement is mandatory. AI-component projects must engage the AI4HEALTH consortium. Proposals submitted via KWF GMS; Dutch-based institutions expected.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
Boost
Deadline: 7 Jul 2026~€150,000 per project, including VATPipeline
Deadline: 7 Jul 2026€1M–€2.5M (Phase I/I-II); €1M–€5M (Phase II/III)KWF Pipeline Call 2026
Deadline: 7 Jul 2026€1M-€5MExploration Call 2026-3
Deadline: 1 Sept 2026Lead4Life
Deadline: 22 Sept 2026€0.5M–€2M per project (total PPP subsidy budget €5M)
Browse Related
Could Validation of Biomarkers be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →